Patents by Inventor Dennis Carson

Dennis Carson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050065116
    Abstract: The invention provides derivatives of thiazolo[4,5-d1]pyrimidine and their use as inhibitors of proinflammatory cytokines.
    Type: Application
    Filed: September 28, 2004
    Publication date: March 24, 2005
    Inventors: Dennis Carson, Howard Cottam, Lynn Deng
  • Publication number: 20050004144
    Abstract: The present invention provides a broad-spectrum, long-lasting, and non-toxic combination of synthetic immunostimulatory agents, which are useful for activating the immune system of a mammal and treating diseases such as cancer and autoimmune disease. These agents include TLR-ligands and ligand analogs which induce interferon production, in combination with inhibitors of inosine monophosphate dehydrogenase (IMPDH), that further enhance the induction of interferon production.
    Type: Application
    Filed: April 14, 2004
    Publication date: January 6, 2005
    Applicant: REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Dennis Carson, Howard Cottam, Jongdae Lee
  • Publication number: 20030212028
    Abstract: The present invention features methods for treatment or prevention of infection by intracellular pathogens (e.g., Mycobacterium species) by administration of an immunomodulatory nucleic acid molecule. In one embodiment, immunomodulatory nucleic acid molecule are administered in combination with another anti-pathogenic agent to provide a synergistic anti-pathogenic effect.
    Type: Application
    Filed: January 28, 2003
    Publication date: November 13, 2003
    Inventors: Eyal Raz, Richard Kornbluth, Antonino Catanzaro, Tomoko Hayashi, Dennis Carson
  • Patent number: 6552006
    Abstract: The present invention features methods for treatment or prevention of infection by intracellular pathogens (e.g., Mycobacterium species) by administration of an immunomodulatory nucleic acid molecule. In one embodiment, immunomodulatory nucleic acid molecule are administered in combination with another anti-pathogenic agent to provide a synergistic anti-pathogenic effect.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: April 22, 2003
    Assignees: The Regents of the University of California, The United States of America as represented by the Department of Veteran Affairs
    Inventors: Eyal Raz, Richard Kornbluth, Antonio Catanzaro, Tomoko Hayashi, Dennis Carson
  • Publication number: 20020086295
    Abstract: The present invention features methods for treatment or prevention of infection by intracellular pathogens (e.g., Mycobacterium species) by administration of an immunomodulatory nucleic acid molecule. In one embodiment, immunomodulatory nucleic acid molecule are administered in combination with another anti-pathogenic agent to provide a synergistic anti-pathogenic effect.
    Type: Application
    Filed: January 30, 2001
    Publication date: July 4, 2002
    Inventors: Eyal Raz, Richard Kornbluth, Antonino Catanzaro, Tomoko Hayashi, Dennis Carson
  • Patent number: 6147123
    Abstract: New methods are described for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3, 7-dimethylxanthine.
    Type: Grant
    Filed: March 23, 1999
    Date of Patent: November 14, 2000
    Assignee: The Regents of the University of California
    Inventors: Mario Chojkier, Dennis Carson
  • Patent number: 6075027
    Abstract: New methods are described for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3, 7-dimethylxanthine.
    Type: Grant
    Filed: March 23, 1999
    Date of Patent: June 13, 2000
    Assignee: The Regents of The University of California
    Inventors: Mario Chojkier, Dennis Carson